Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Award for Novel Cancer Immunotherapy Treatment, Granted for Prostate Cancer, Colon Cancer, Ovarian Cancer, Kidney Cancer, Breast Cancer, Glioblastoma, Melanoma, and Lung Cancer.
May 23, 2023 08:01 ET | Ocean Biomedical, Inc.
Latest patent broadens protection around OCEA’s platform of first-in-class anti-CHi3L1 therapeutic immunotherapy candidates, based on the breakthrough discovery by scientific co-founder, Dr. Jack A....
GRI Bio (NASDAQ: GRI) Provides Business Outlook and Highlights Upcoming Milestones for Innovative Pipeline of NKT Cell Modulators
May 22, 2023 08:45 ET | GRI Bio, Inc.
Rapidly advancing clinical pipeline in potential high-value inflammatory, fibrotic and autoimmune diseases Leading NKT regulation technology targeting earlier in the inflammatory cascade to...
Mount Sinai Brooklyn Expands Cancer Services, Infusion Center in $4 Million Project
May 19, 2023 14:20 ET | Mount Sinai Health System
NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) -- The Mount Sinai Health System today held a grand opening of the expansion of the Mount Sinai Brooklyn Ambulatory Infusion Center, a cancer treatment center...
Fentanyl Awareness D
Fentanyl Awareness Day Breakthrough: New Test Strips Detect “Tranq,” Giving Patients Better, More Precise Treatment
May 09, 2023 09:00 ET | Gallus Medical Detox Centers
Denver, CO, May 09, 2023 (GLOBE NEWSWIRE) -- Gallus Medical Detox Centers is now testing for “Tranq.” The announcement comes as experts educate about fentanyl as we mark National Fentanyl Awareness...
Contrive Datum Insights_Logo.jpg
The Acquired Aplastic Anemia Market is Projected To Reach USD 10.25 billion By 2030, From USD 7.27 billion in 2022,Registering a CAGR Of 4.20% During The Forecast Period 2023-2030| Data By Contrive Datum Insights Pvt Ltd.
May 08, 2023 13:20 ET | Contrive Datum Insights Pvt Ltd
Farmington, May 08, 2023 (GLOBE NEWSWIRE) -- The Global Acquired Aplastic Anemia Market size was valued at USD 7.27 billion in 2022 and is projected to reach USD 10.25 billion by 2030, growing at a...
Global Breast Cancer Market Size To Grow USD 85.5 Billion By 2032 | CAGR of 10.3%
April 27, 2023 08:10 ET | SPHERICAL INSIGHTS LLP
New York, United States , April 27, 2023 (GLOBE NEWSWIRE) -- The Global Breast Cancer Market Size is to grow from USD 31.9 Billion in 2022 to USD 85.5 Billion by 2032, at a Compound Annual Growth...
GRI Bio (NASDAQ: GRI) Announces Appointment of Leanne Kelly as Chief Financial Officer
April 25, 2023 08:45 ET | GRI Bio, Inc.
- Financial executive bringing over 20 years of experience in accounting, finance and management with a foundation established from big four accounting firm LA JOLLA, CA, April 25, 2023 (GLOBE...
Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression
April 21, 2023 08:30 ET | Clearmind Medicine Inc.
The application is for a novel psychedelic-based combination, of Clearmind's MEAI and SciSparc's Cannamide™ Tel Aviv, Israel / Vancouver, Canada, April 21, 2023 (GLOBE NEWSWIRE) --...
Transcatheter Embolization And Occlusion Devices Market to Garner Significant Profits US$ 11 Bn in 2032
April 18, 2023 21:15 ET | Market.Us
New York, April 18, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the global transcatheter embolization and occlusion devices market was valued at US$ 4 billion in 2022 and is expected to grow...
Tiziana Life Sciences to Pursue Development of Intranasal Foralumab for the Treatment of Long COVID
April 13, 2023 07:00 ET | Tiziana Life Sciences Ltd.
Long COVID remains a high unmet need causing a myriad of complications for patients and costing the U.S. healthcare system an estimated $2.6 trillionThe role of activated microglia is well-established...